Poietis
PrivateLast Round
Series A
Mar 27, 2018
Total Funding Raised
$11.98M
Company Overview
Poietis operates in Healthcare & Life Sciences and is based in Pessac. Its latest recorded funding round was a Series A round in March 2018.
Poietis is a biotechnology company that develops and produces human tissues using 4D laser-assisted bioprinting for pharmaceutical, cosmetic, and regenerative medicine applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Poietis Comparables
Compare Poietis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brinter | 85% | |
| Regemat 3D | 85% | |
| Fluicell AB | 84% |
For institutional investors. Book with your work email.
Poietis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 27, 2018 | ||||
| Seed | Dec 17, 2015 |
For institutional investors. Book with your work email.
Poietis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nouvelle-Aquitaine Co-investissement | Crowdfunding, Series A |
| Aquitaine Science Transfert | Seed |
| Michelin Development | Seed |
| WiSeed | Crowdfunding, Series A, Seed |
| Bpifrance | Crowdfunding, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2018
Raised $6.2M from government and other investors.
- Dec 17, 2015
$2.75M raised from Aquitaine Science Transfert and others.
For institutional investors. Book with your work email.
Poietis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Poietis's valuation, stock price, and market status.
Is Poietis a public or private company?
Poietis is a private company.
What is the current stock price of Poietis?
Poietis is a private company, so its shares have no public market price. Caplight tracks Poietis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Poietis worth (valuation)?
Valuation information for Poietis is not publicly available.
Can I buy Poietis stock?
Poietis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Poietis's last funding round?
Poietis's most recent funding round was Series A on March 27, 2018.
Who are the main investors in Poietis?
Key investors in Poietis include Nouvelle-Aquitaine Co-investissement, Aquitaine Science Transfert, Michelin Development, WiSeed, Bpifrance.
Will Poietis IPO soon?
No public IPO plans have been announced for Poietis.
How can I track Poietis secondary market activity?
Caplight tracks bids, offers, and trades in Poietis's shares on secondary markets.